Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
| 301 | 3 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY//LEVOSIMENDAN//PHARMACOLOGY & PHARMACY | 41522 |
| 1503 | 2 | NEBIVOLOL//CARVEDILOL//BETA BLOCKERS | 7786 |
| 18835 | 1 | NEBIVOLOL//NEBIVOLOL HYDROCHLORIDE//THIRD GENERATION BETA BLOCKERS | 557 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | NEBIVOLOL | authKW | 7783691 | 40% | 61% | 225 |
| 2 | NEBIVOLOL HYDROCHLORIDE | authKW | 404151 | 2% | 71% | 10 |
| 3 | THIRD GENERATION BETA BLOCKERS | authKW | 282910 | 1% | 100% | 5 |
| 4 | VASODILATING BETA BLOCKERS | authKW | 277247 | 1% | 70% | 7 |
| 5 | DL NEBIVOLOL | authKW | 169746 | 1% | 100% | 3 |
| 6 | BETA BLOCKERS | authKW | 138247 | 16% | 3% | 90 |
| 7 | ALTERED LEFT VENTRICULAR FUNCTION | authKW | 113164 | 0% | 100% | 2 |
| 8 | BETA1 ADRENOCEPTOR BLOCKERS | authKW | 113164 | 0% | 100% | 2 |
| 9 | D L ENANTIOMERS | authKW | 113164 | 0% | 100% | 2 |
| 10 | ERECTILE DYSFUNCTION AND HYPERTENSIVE AGENTS | authKW | 113164 | 0% | 100% | 2 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Peripheral Vascular Diseases | 3451 | 23% | 0% | 130 |
| 2 | Cardiac & Cardiovascular System | 2374 | 26% | 0% | 146 |
| 3 | Pharmacology & Pharmacy | 2110 | 37% | 0% | 204 |
| 4 | Medicine, General & Internal | 55 | 6% | 0% | 35 |
| 5 | Urology & Nephrology | 29 | 3% | 0% | 16 |
| 6 | Physiology | 19 | 3% | 0% | 17 |
| 7 | Medicine, Research & Experimental | 18 | 3% | 0% | 19 |
| 8 | Toxicology | 6 | 2% | 0% | 10 |
| 9 | Endocrinology & Metabolism | 5 | 3% | 0% | 14 |
| 10 | Theater | 5 | 0% | 0% | 1 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | INT CLIN RD | 113164 | 0% | 100% | 2 |
| 2 | ATLANTA VASC FDN | 75441 | 0% | 67% | 2 |
| 3 | BIOMED SURG SCI MED D | 75441 | 0% | 67% | 2 |
| 4 | DIABET CARDIOVASC EXCELLENCE | 63651 | 1% | 38% | 3 |
| 5 | BIOL CLINSERV PHARMCOLU644 | 56582 | 0% | 100% | 1 |
| 6 | CARDIOLUNIV HOSP WALES | 56582 | 0% | 100% | 1 |
| 7 | CHAIR THER EUT CLIN PHARMACOL | 56582 | 0% | 100% | 1 |
| 8 | CLIN ANAL FOOD SCI TOXICOL | 56582 | 0% | 100% | 1 |
| 9 | CNRS GRP MECAN INGN CELLULAIRE TISSULAIRE 756 | 56582 | 0% | 100% | 1 |
| 10 | COMMERCIAL RD | 56582 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | RUSSIAN JOURNAL OF CARDIOLOGY | 12019 | 2% | 2% | 10 |
| 2 | JOURNAL OF CLINICAL HYPERTENSION | 10705 | 3% | 1% | 15 |
| 3 | PERFUSION | 8517 | 1% | 2% | 7 |
| 4 | CARDIOVASCULAR THERAPY AND PREVENTION | 6134 | 2% | 1% | 9 |
| 5 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 4580 | 5% | 0% | 30 |
| 6 | JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION | 4016 | 1% | 1% | 7 |
| 7 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS | 3221 | 1% | 1% | 6 |
| 8 | KARDIOLOGIYA | 3061 | 3% | 0% | 19 |
| 9 | JOURNAL OF HUMAN HYPERTENSION | 2945 | 3% | 0% | 14 |
| 10 | CARDIOVASCULAR DRUGS AND THERAPY | 2861 | 2% | 1% | 10 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |